98-25357. Draft ``Guidance for Industry: Interpretation of On-farm Feed Manufacturing and Mixing Operations''; Availability; Request for Comments  

  • [Federal Register Volume 63, Number 184 (Wednesday, September 23, 1998)]
    [Notices]
    [Pages 50918-50919]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-25357]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98D-0727]
    
    
    Draft ``Guidance for Industry: Interpretation of On-farm Feed 
    Manufacturing and Mixing Operations''; Availability; Request for 
    Comments
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing the 
    availability of a draft guidance entitled ``Interpretation of On-farm 
    Feed Manufacturing and Mixing Operations.'' The draft guidance is 
    intended to clarify the applicability of certain sections of the Animal 
    Proteins Prohibited from Use in Animal Feed regulation to ruminant 
    feeders. The agency is requesting comments on this draft guidance.
    
    DATES: Submit written comments by November 23, 1998.
    
    ADDRESSES: Submit written requests for single copies of this draft 
    guidance to the Communications Staff (HFV-12), Center for Veterinary 
    Medicine, Food and Drug Administration, 7500 Standish Pl., Rockville, 
    MD 20855. Send one self-addressed adhesive label to assist that office 
    in processing your requests.
         Submit written comments on the draft guidance to the Dockets 
    Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers 
    Lane, rm. 1061, Rockville, MD 20852. Comments should be identified with 
    the full title of the draft guidance and the docket number found in 
    brackets in the heading of this document. See the SUPPLEMENTARY 
    INFORMATION section for information on electronic access to the draft 
    guidance.
    
     FOR FURTHER INFORMATION CONTACT: Gloria J. Dunnavan, Center for 
    Veterinary Medicine (HFV-230), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-594-1726, E-mail: 
    gdunnava@bangate.fda.gov.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
         Section 589.2000 Animal proteins prohibited from use in animal 
    feed (21 CFR 589.2000) defines ``feed manufacturer'' to include ``on-
    farm feed manufacturing and mixing operation.'' This draft guidance 
    makes it clear that an operation that mixes, but does not manufacture 
    feed onfarm is not considered a feed manufacturer by FDA. Rather such 
    mixing operations are ruminant feeders. While all ruminant feeders are 
    subject to the regulation, the regulation imposes significantly 
    different requirements on ruminant feeders that are also ``feed 
    manufacturers.'' For this reason, FDA finds it necessary to clarify the 
    phrase ``on-farm feed manufacturing and mixing operations.''
         FDA believes that a ruminant producer who mixes total mixed 
    rations (TMR's), a complete mix of the cow's daily diet, for the 
    animals under the producer's control is not
    
    [[Page 50919]]
    
    ``manufacturing and mixing.'' This draft guidance provides our 
    rationale for this interpretation.
         The agency has adopted Good Guidance Practices (GGP's), which set 
    forth the agency's policies and procedures for the development, 
    issuance, and use of guidance documents (62 FR 8961, February 27, 
    1997). This draft guidance is issued as a Level 1 guidance consistent 
    with GGP's. If finalized, this document will represent current FDA 
    thinking on on-farm feed manufacturing and mixing operations and their 
    responsibilities under Sec. 589.2000. The guidance will not create or 
    confer any rights for or on any person and will not operate to bind FDA 
    or the public. Alternate approaches may be used if they satisfy the 
    requirements of applicable statutes, regulations, or both.
    
    II. Comments
    
        Interested persons should submit written comments on or before 
    November 23, 1998, to the Dockets Management Branch (address above) 
    regarding this draft guidance. Two copies of any comments are to be 
    submitted, except that individuals may submit one copy. Comments should 
    be identified with the docket number found in brackets in the heading 
    of this document. A copy of the draft guidance and received comments 
    are available for public examination in the Dockets Management Branch 
    between 9 a.m. and 4 p.m., Monday through Friday.
    
    III. Electronic Access
    
        Persons with access to the Internet may obtain the draft guidance 
    using the World Wide Web (WWW). For WWW access, connect to CVM at 
    ``http://www.fda.gov/cvm''.
    
        Dated: September 8, 1998.
     William K. Hubbard,
     Associate Commissioner for Policy Coordination.
    [FR Doc. 98-25357 Filed 9-22-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
09/23/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-25357
Dates:
Submit written comments by November 23, 1998.
Pages:
50918-50919 (2 pages)
Docket Numbers:
Docket No. 98D-0727
PDF File:
98-25357.pdf